Chen K, Li J, Wang J, Xia Y, Dai W, Wang F, et al
As more patients use GLP-1 medications such as semaglutide and tirzepatide, clinicians are starting to ask an important question: are these drugs quietly contributing to the Read More Fragmented Care in the GLP-1 Era: What Happens When Multiple Providers Prescribe the Same Therapy
The safest approach, according to current clinical guidance, is to restart semaglutide at its lowest available dose (0.25 mg weekly) and titrate up gradually following the standard schedule
Some people experience minimal weight reduction with GLP-1s, whereas others have robust weight reductions of 30%
Usually secondary to severe dehydration from persistent vomiting or diarrhea
The conundrum is further complicated by the increasing number of studies highlighting (generalized) JHM as a possible predisposing factor and/or noncasually associated features for a series of extra-articular disorders (Table 4) [3864]